| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.460 | 4.008 | 3.974 | 3.901 | 3.825 | 1.240 | 1.213 | 1.217 | 1.213 | 1.206 |
| Total Income - EUR | 4.522 | 4.018 | 3.998 | 3.901 | 4.018 | 1.240 | 1.213 | 1.217 | 1.213 | 1.206 |
| Total Expenses - EUR | 409 | 416 | 440 | 372 | 188 | 154 | 358 | 586 | 695 | 626 |
| Gross Profit/Loss - EUR | 4.114 | 3.602 | 3.558 | 3.529 | 3.829 | 1.087 | 854 | 631 | 518 | 580 |
| Net Profit/Loss - EUR | 3.978 | 3.481 | 3.438 | 3.412 | 3.709 | 1.049 | 821 | 597 | 441 | 509 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Davimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 13.454 | 16.765 | 14.495 | 18.693 | 22.165 | 22.747 | 22.593 | 23.487 | 20.677 | 21.178 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.694 | 3.364 | 8.045 | 12.522 | 14.631 | 15.830 | 16.042 | 16.598 | 8.462 | 9.620 |
| Cash | 11.760 | 13.402 | 6.450 | 6.171 | 7.534 | 6.918 | 6.552 | 6.888 | 12.216 | 11.558 |
| Shareholders Funds | -175 | 3.309 | 6.691 | 9.980 | 13.495 | 14.289 | 14.793 | 15.436 | 15.830 | 16.250 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.628 | 13.457 | 7.804 | 8.713 | 8.670 | 8.459 | 7.801 | 8.051 | 4.847 | 4.929 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7739 - 7739" | |||||||||
| CAEN Financial Year |
7739
|
|||||||||
Comments - Davimed S.r.l.